nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—IL3—hematopoietic system—thymus cancer	0.0599	0.0923	CbGeAlD
Amlexanox—IL3—lymphoid tissue—thymus cancer	0.0422	0.065	CbGeAlD
Amlexanox—IL3—bone marrow—thymus cancer	0.0384	0.0592	CbGeAlD
Amlexanox—S100A13—neck—thymus cancer	0.0382	0.0588	CbGeAlD
Amlexanox—Throat sore—Octreotide—thymus cancer	0.0294	0.214	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Octreotide—thymus cancer	0.0291	0.212	CcSEcCtD
Amlexanox—S100A12—hematopoietic system—thymus cancer	0.028	0.0432	CbGeAlD
Amlexanox—S100A13—epithelium—thymus cancer	0.026	0.04	CbGeAlD
Amlexanox—S100A12—epithelium—thymus cancer	0.0256	0.0395	CbGeAlD
Amlexanox—IL3—lymph node—thymus cancer	0.0238	0.0367	CbGeAlD
Amlexanox—FGF1—neck—thymus cancer	0.0235	0.0362	CbGeAlD
Amlexanox—Oropharyngeal pain—Octreotide—thymus cancer	0.0233	0.17	CcSEcCtD
Amlexanox—S100A12—pituitary gland—thymus cancer	0.0208	0.0321	CbGeAlD
Amlexanox—S100A12—lymphoid tissue—thymus cancer	0.0197	0.0304	CbGeAlD
Amlexanox—Mouth ulceration—Octreotide—thymus cancer	0.0192	0.139	CcSEcCtD
Amlexanox—S100A13—thyroid gland—thymus cancer	0.0182	0.028	CbGeAlD
Amlexanox—S100A12—bone marrow—thymus cancer	0.018	0.0277	CbGeAlD
Amlexanox—FGF1—hematopoietic system—thymus cancer	0.0175	0.027	CbGeAlD
Amlexanox—S100A13—lung—thymus cancer	0.0165	0.0254	CbGeAlD
Amlexanox—S100A12—lung—thymus cancer	0.0163	0.0251	CbGeAlD
Amlexanox—FGF1—epithelium—thymus cancer	0.016	0.0247	CbGeAlD
Amlexanox—FGF1—cardiac atrium—thymus cancer	0.0133	0.0205	CbGeAlD
Amlexanox—FGF1—pituitary gland—thymus cancer	0.013	0.02	CbGeAlD
Amlexanox—S100A12—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CYLD—thymus cancer	0.0123	0.0577	CbGpPWpGaD
Amlexanox—FGF1—lymphoid tissue—thymus cancer	0.0123	0.019	CbGeAlD
Amlexanox—PDE4D—thyroid gland—thymus cancer	0.012	0.0184	CbGeAlD
Amlexanox—S100A13—lymph node—thymus cancer	0.0113	0.0174	CbGeAlD
Amlexanox—FGF1—thyroid gland—thymus cancer	0.0112	0.0172	CbGeAlD
Amlexanox—S100A12—lymph node—thymus cancer	0.0111	0.0172	CbGeAlD
Amlexanox—PDE4D—lung—thymus cancer	0.0109	0.0167	CbGeAlD
Amlexanox—PDE4A—thyroid gland—thymus cancer	0.0106	0.0163	CbGeAlD
Amlexanox—IL3—Cytokines and Inflammatory Response—CD4—thymus cancer	0.0103	0.0481	CbGpPWpGaD
Amlexanox—FGF1—lung—thymus cancer	0.0102	0.0157	CbGeAlD
Amlexanox—PDE4B—hematopoietic system—thymus cancer	0.00987	0.0152	CbGeAlD
Amlexanox—PDE4A—lung—thymus cancer	0.00962	0.0148	CbGeAlD
Amlexanox—IL3—Cytokines and Inflammatory Response—IL2—thymus cancer	0.00946	0.0443	CbGpPWpGaD
Amlexanox—IL3—Interleukin receptor SHC signaling—IL2—thymus cancer	0.00919	0.043	CbGpPWpGaD
Amlexanox—IL3—Calcium signaling in the CD4+ TCR pathway—IL2—thymus cancer	0.00894	0.0418	CbGpPWpGaD
Amlexanox—IL3—Differentiation Pathway—KIT—thymus cancer	0.00848	0.0397	CbGpPWpGaD
Amlexanox—PDE4B—cardiac atrium—thymus cancer	0.0075	0.0116	CbGeAlD
Amlexanox—PDE4D—lymph node—thymus cancer	0.00743	0.0115	CbGeAlD
Amlexanox—Nervous system disorder—Octreotide—thymus cancer	0.00742	0.054	CcSEcCtD
Amlexanox—PDE4B—pituitary gland—thymus cancer	0.00732	0.0113	CbGeAlD
Amlexanox—FGF1—lymph node—thymus cancer	0.00695	0.0107	CbGeAlD
Amlexanox—PDE4B—lymphoid tissue—thymus cancer	0.00695	0.0107	CbGeAlD
Amlexanox—Paraesthesia—Octreotide—thymus cancer	0.00679	0.0494	CcSEcCtD
Amlexanox—PDE4A—lymph node—thymus cancer	0.00658	0.0101	CbGeAlD
Amlexanox—Gastrointestinal disorder—Octreotide—thymus cancer	0.00653	0.0475	CcSEcCtD
Amlexanox—Pain—Octreotide—thymus cancer	0.00647	0.047	CcSEcCtD
Amlexanox—IL3—Interleukin-3, 5 and GM-CSF signaling—IL2—thymus cancer	0.0064	0.03	CbGpPWpGaD
Amlexanox—PDE4B—bone marrow—thymus cancer	0.00633	0.00975	CbGeAlD
Amlexanox—PDE4B—thyroid gland—thymus cancer	0.00631	0.00973	CbGeAlD
Amlexanox—IL3—Interleukin-2 signaling—IL2—thymus cancer	0.00607	0.0284	CbGpPWpGaD
Amlexanox—IL3—G beta:gamma signalling through PI3Kgamma—IL2—thymus cancer	0.00597	0.0279	CbGpPWpGaD
Amlexanox—IL3—GPVI-mediated activation cascade—IL2—thymus cancer	0.00587	0.0275	CbGpPWpGaD
Amlexanox—IL3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—thymus cancer	0.00578	0.027	CbGpPWpGaD
Amlexanox—PDE4B—lung—thymus cancer	0.00573	0.00884	CbGeAlD
Amlexanox—IL3—G-protein beta:gamma signalling—IL2—thymus cancer	0.00569	0.0266	CbGpPWpGaD
Amlexanox—Headache—Octreotide—thymus cancer	0.00474	0.0345	CcSEcCtD
Amlexanox—Nausea—Octreotide—thymus cancer	0.00449	0.0327	CcSEcCtD
Amlexanox—PDE4B—lymph node—thymus cancer	0.00392	0.00604	CbGeAlD
Amlexanox—FGF1—Differentiation Pathway—KIT—thymus cancer	0.00389	0.0182	CbGpPWpGaD
Amlexanox—IL3—Senescence and Autophagy in Cancer—CDKN2A—thymus cancer	0.00368	0.0172	CbGpPWpGaD
Amlexanox—IL3—G beta:gamma signalling through PI3Kgamma—AKT1—thymus cancer	0.00324	0.0152	CbGpPWpGaD
Amlexanox—IL3—IL-3 Signaling Pathway—AKT1—thymus cancer	0.00318	0.0149	CbGpPWpGaD
Amlexanox—IL3—GPVI-mediated activation cascade—AKT1—thymus cancer	0.00318	0.0149	CbGpPWpGaD
Amlexanox—IL3—Signaling by Interleukins—IL2—thymus cancer	0.00312	0.0146	CbGpPWpGaD
Amlexanox—IL3—G-protein beta:gamma signalling—AKT1—thymus cancer	0.00308	0.0144	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CYLD—thymus cancer	0.00254	0.0119	CbGpPWpGaD
Amlexanox—FGF1—Constitutive PI3K/AKT Signaling in Cancer—KIT—thymus cancer	0.00244	0.0114	CbGpPWpGaD
Amlexanox—FGF1—PI-3K cascade—KIT—thymus cancer	0.0022	0.0103	CbGpPWpGaD
Amlexanox—FGF1—PI3K/AKT activation—KIT—thymus cancer	0.00214	0.01	CbGpPWpGaD
Amlexanox—FGF1—GAB1 signalosome—KIT—thymus cancer	0.00213	0.00995	CbGpPWpGaD
Amlexanox—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—thymus cancer	0.00208	0.00972	CbGpPWpGaD
Amlexanox—IL3—Senescence and Autophagy in Cancer—TP53—thymus cancer	0.00205	0.00959	CbGpPWpGaD
Amlexanox—IL3—Immune System—CYLD—thymus cancer	0.00184	0.00863	CbGpPWpGaD
Amlexanox—IL3—Platelet activation, signaling and aggregation—IL2—thymus cancer	0.00176	0.00824	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—KIT—thymus cancer	0.00164	0.00768	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—KIT—thymus cancer	0.00157	0.00735	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—KIT—thymus cancer	0.00155	0.00723	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CYLD—thymus cancer	0.00148	0.00691	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—KIT—thymus cancer	0.00148	0.00691	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—KIT—thymus cancer	0.00147	0.00687	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—KIT—thymus cancer	0.00146	0.00684	CbGpPWpGaD
Amlexanox—IL3—Cytokine Signaling in Immune system—IL2—thymus cancer	0.00146	0.00682	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—KIT—thymus cancer	0.00145	0.00681	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CYLD—thymus cancer	0.00145	0.00678	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—KIT—thymus cancer	0.00143	0.00671	CbGpPWpGaD
Amlexanox—PDE4D—TSH signaling pathway—AKT1—thymus cancer	0.0014	0.00655	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—KIT—thymus cancer	0.00137	0.0064	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	0.00137	0.0064	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—KIT—thymus cancer	0.00137	0.0064	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—KIT—thymus cancer	0.00136	0.00635	CbGpPWpGaD
Amlexanox—FGF1—FGF signaling pathway—AKT1—thymus cancer	0.00135	0.00632	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—KIT—thymus cancer	0.00134	0.00629	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—KIT—thymus cancer	0.00134	0.00626	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.00127	0.00594	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—KIT—thymus cancer	0.00127	0.00593	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—KIT—thymus cancer	0.00121	0.00567	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.00107	0.00502	CbGpPWpGaD
Amlexanox—IL3—Platelet activation, signaling and aggregation—AKT1—thymus cancer	0.000954	0.00447	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MAML2—thymus cancer	0.000947	0.00443	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—KIT—thymus cancer	0.000932	0.00436	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—KIT—thymus cancer	0.00093	0.00435	CbGpPWpGaD
Amlexanox—FGF1—Constitutive PI3K/AKT Signaling in Cancer—AKT1—thymus cancer	0.00093	0.00435	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—IL2—thymus cancer	0.000907	0.00425	CbGpPWpGaD
Amlexanox—IL3—Immune System—CD8A—thymus cancer	0.0009	0.00421	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CYLD—thymus cancer	0.000844	0.00395	CbGpPWpGaD
Amlexanox—FGF1—PI-3K cascade—AKT1—thymus cancer	0.000838	0.00392	CbGpPWpGaD
Amlexanox—FGF1—PI3K/AKT activation—AKT1—thymus cancer	0.000818	0.00383	CbGpPWpGaD
Amlexanox—FGF1—GAB1 signalosome—AKT1—thymus cancer	0.000811	0.0038	CbGpPWpGaD
Amlexanox—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—thymus cancer	0.000793	0.00371	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD8A—thymus cancer	0.000721	0.00338	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CD4—thymus cancer	0.000711	0.00333	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD8A—thymus cancer	0.00068	0.00318	CbGpPWpGaD
Amlexanox—IL3—Immune System—KIT—thymus cancer	0.000676	0.00316	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—AKT1—thymus cancer	0.000626	0.00293	CbGpPWpGaD
Amlexanox—FGF1—Disease—MAML2—thymus cancer	0.000619	0.0029	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MAML2—thymus cancer	0.000607	0.00284	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—AKT1—thymus cancer	0.000599	0.0028	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—AKT1—thymus cancer	0.00059	0.00276	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TP53—thymus cancer	0.000583	0.00273	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.000582	0.00272	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—IL2—thymus cancer	0.000573	0.00268	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—AKT1—thymus cancer	0.000563	0.00264	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—AKT1—thymus cancer	0.00056	0.00262	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—AKT1—thymus cancer	0.000558	0.00261	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—AKT1—thymus cancer	0.000555	0.0026	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	0.000547	0.00256	CbGpPWpGaD
Amlexanox—S100A12—Immune System—KIT—thymus cancer	0.000542	0.00254	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—KIT—thymus cancer	0.000532	0.00249	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAML2—thymus cancer	0.000528	0.00247	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—AKT1—thymus cancer	0.000522	0.00244	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000522	0.00244	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—AKT1—thymus cancer	0.000522	0.00244	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL2—thymus cancer	0.000521	0.00244	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—AKT1—thymus cancer	0.000517	0.00242	CbGpPWpGaD
Amlexanox—IL3—Immune System—CD4—thymus cancer	0.000517	0.00242	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—AKT1—thymus cancer	0.000513	0.0024	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—AKT1—thymus cancer	0.000511	0.00239	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—KIT—thymus cancer	0.00051	0.00239	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAML2—thymus cancer	0.000503	0.00235	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—AKT1—thymus cancer	0.000492	0.0023	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.000491	0.0023	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—AKT1—thymus cancer	0.000483	0.00226	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL2—thymus cancer	0.000476	0.00223	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAML2—thymus cancer	0.000465	0.00218	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	0.000462	0.00216	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—KIT—thymus cancer	0.000437	0.00205	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAML2—thymus cancer	0.000434	0.00203	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD4—thymus cancer	0.000414	0.00194	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD8A—thymus cancer	0.000412	0.00193	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CD4—thymus cancer	0.000407	0.0019	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD4—thymus cancer	0.00039	0.00183	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL2—thymus cancer	0.000381	0.00178	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—IL2—thymus cancer	0.000367	0.00172	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—AKT1—thymus cancer	0.000356	0.00166	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—AKT1—thymus cancer	0.000355	0.00166	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL2—thymus cancer	0.000334	0.00156	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—IL2—thymus cancer	0.00032	0.0015	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—AKT1—thymus cancer	0.000311	0.00146	CbGpPWpGaD
Amlexanox—FGF1—Immune System—KIT—thymus cancer	0.00031	0.00145	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL2—thymus cancer	0.000308	0.00144	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—IL2—thymus cancer	0.000304	0.00142	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL2—thymus cancer	0.00029	0.00136	CbGpPWpGaD
Amlexanox—FGF1—Disease—KIT—thymus cancer	0.000286	0.00134	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—AKT1—thymus cancer	0.000282	0.00132	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—IL2—thymus cancer	0.000282	0.00132	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—KIT—thymus cancer	0.00028	0.00131	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL2—thymus cancer	0.000276	0.00129	CbGpPWpGaD
Amlexanox—IL3—Immune System—AKT1—thymus cancer	0.000258	0.00121	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL2—thymus cancer	0.000256	0.0012	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—KIT—thymus cancer	0.000244	0.00114	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD4—thymus cancer	0.000237	0.00111	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—KIT—thymus cancer	0.000232	0.00109	CbGpPWpGaD
Amlexanox—FGF1—Disease—CD4—thymus cancer	0.000219	0.00102	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL2—thymus cancer	0.000218	0.00102	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—KIT—thymus cancer	0.000215	0.001	CbGpPWpGaD
Amlexanox—S100A12—Immune System—AKT1—thymus cancer	0.000207	0.000968	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—AKT1—thymus cancer	0.000203	0.000949	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—KIT—thymus cancer	0.0002	0.000937	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—AKT1—thymus cancer	0.000199	0.000932	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TP53—thymus cancer	0.000198	0.000924	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL2—thymus cancer	0.000197	0.000922	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—AKT1—thymus cancer	0.000195	0.000912	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—AKT1—thymus cancer	0.000181	0.000847	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—AKT1—thymus cancer	0.000173	0.000812	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL2—thymus cancer	0.000172	0.000803	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—AKT1—thymus cancer	0.000167	0.000781	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—AKT1—thymus cancer	0.000165	0.000773	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL2—thymus cancer	0.000163	0.000764	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—AKT1—thymus cancer	0.000157	0.000737	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—AKT1—thymus cancer	0.000153	0.000715	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL2—thymus cancer	0.000151	0.000707	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—AKT1—thymus cancer	0.00015	0.000702	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL2—thymus cancer	0.000141	0.000659	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—AKT1—thymus cancer	0.000139	0.000649	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TP53—thymus cancer	0.000127	0.000592	CbGpPWpGaD
Amlexanox—FGF1—Immune System—AKT1—thymus cancer	0.000118	0.000553	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TP53—thymus cancer	0.00011	0.000516	CbGpPWpGaD
Amlexanox—FGF1—Disease—AKT1—thymus cancer	0.000109	0.000511	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—AKT1—thymus cancer	0.000107	0.0005	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TP53—thymus cancer	0.000105	0.000491	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TP53—thymus cancer	9.7e-05	0.000454	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—AKT1—thymus cancer	9.3e-05	0.000435	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TP53—thymus cancer	9.05e-05	0.000423	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—AKT1—thymus cancer	8.85e-05	0.000414	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AKT1—thymus cancer	8.19e-05	0.000383	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AKT1—thymus cancer	7.64e-05	0.000358	CbGpPWpGaD
